2005
Prevalence of, Evolution of, and Risk Factors for Fat Atrophy and Fat Deposition in a Cohort of HIV-Infected Men and Women
Jacobson DL, Knox T, Spiegelman D, Skinner S, Gorbach S, Wanke C. Prevalence of, Evolution of, and Risk Factors for Fat Atrophy and Fat Deposition in a Cohort of HIV-Infected Men and Women. Clinical Infectious Diseases 2005, 40: 1837-1845. PMID: 15909274, DOI: 10.1086/430379.Peer-Reviewed Original ResearchConceptsFat atrophyRisk factorsFat depositionBaseline prevalenceCentral fat depositionHIV-Infected MenActive antiretroviral therapyHigh triglyceride levelsHuman immunodeficiency virusNutrition Examination SurveyPercent of subjectsSkin-fold measurementsBody fat levelsAbacavir useHIV loadStavudine useAntiretroviral therapyHip ratioImmunodeficiency virusExamination SurveyTriglyceride levelsNational HealthHigh school educationSmaller hipIndependent syndrome
2004
Understanding the Role of HIV Load in Determining Weight Change in the Era of Highly Active Antiretroviral Therapy
Mwamburi DM, Wilson IB, Jacobson DL, Spiegelman D, Gorbach SL, Knox TA, Wanke CA. Understanding the Role of HIV Load in Determining Weight Change in the Era of Highly Active Antiretroviral Therapy. Clinical Infectious Diseases 2004, 40: 167-173. PMID: 15614708, DOI: 10.1086/426591.Peer-Reviewed Original ResearchConceptsActive antiretroviral therapyVirus loadBody weightAntiretroviral therapyHIV infectionWeight changeStudy visitHuman immunodeficiency virus RNA loadHighly Active Antiretroviral TherapyAbsence of HAARTProspective cohort studyCell count decreaseVirus RNA loadTime of enrollmentStudy intervalRepeated-measures analysisHIV loadHAART useCohort studyRNA loadHAARTPatientsEligible sampleCell countCount decrease